Fairmount Funds Management »

Apogee Therapeutics shares owned by Fairmount Funds Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Fairmount Funds Management from 13F filings

Historical chart of Fairmount Funds Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Fairmount Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Fairmount Funds Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $82M 2.9M 27.94
2023-09-30 $63M 2.9M 21.30